9-羟基-2-甲基玫瑰树碱（NSC 264--137）用于晚期人类癌症的初步试验。 - Suppr

Suppr

超能文献

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.

作者信息

Juret P, Tanguy A, Girard A, Le Talaer J Y, Abbatucci J S, Dat-Xuong N, Le Pecq J B, Paoletti C

出版信息

Eur J Cancer (1965). 1978 Feb;14(2):205-6. doi: 10.1016/0014-2964(78)90180-9.

DOI:10.1016/0014-2964(78)90180-9

PMID:342255

Abstract

摘要

相似文献

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.9-羟基-2-甲基玫瑰树碱（NSC 264--137）用于晚期人类癌症的初步试验。

Eur J Cancer (1965). 1978 Feb;14(2):205-6. doi: 10.1016/0014-2964(78)90180-9.

Hydroxy-9-methyl-2-Ellipticinium (NSC 264-137) in 52 cases of osseous metastases from breast cancer.羟基-9-甲基-2-椭圆玫瑰树碱（NSC 264 - 137）治疗52例乳腺癌骨转移患者。

Eur J Cancer (1965). 1980;Suppl 1:277-9.

[Hydroxy 9-methyl 2-ellipticinium acetate (NSC 264-137). Toxicologic study and therapeutic effect in 100 cancers (author's transl)].[羟基 9-甲基 2-醋酸玫瑰树碱（NSC 264-137）。100 例癌症患者的毒理学研究及治疗效果（作者译）]

Nouv Presse Med. 1979 Apr 21;8(18):1495-8.

Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).玫瑰树碱、玫瑰树碱盐及9-羟基衍生物的抗肿瘤活性、药理学及毒性：2-甲基-9-羟基玫瑰树碱盐（NSC 264-137）的初步临床试验

Recent Results Cancer Res. 1980;74:107-23. doi: 10.1007/978-3-642-81488-4_15.

[Hydroxy-9-methyl-2-ellipticinium (NSC 264-137) for osseous metastases from breast cancer. A 4 year experience (author's transl)].羟基-9-甲基-2-椭圆玫瑰树碱（NSC 264-137）治疗乳腺癌骨转移：4年经验（作者译）

Bull Cancer. 1981;68(3):224-31.

[2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia].

C R Acad Hebd Seances Acad Sci D. 1975 Nov 3;281(18):1365-7.

Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group.9-羟基-2-甲基醋酸椭圆玫瑰树碱（椭圆玫瑰树碱）用于晚期肺癌患者的II期研究。欧洲癌症研究与治疗组织肺癌协作组

Eur J Cancer Clin Oncol. 1989 May;25(5):909-10. doi: 10.1016/0277-5379(89)90140-5.

2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase II study.2-甲基-9-羟基玫瑰树碱醋酸盐（玫瑰树碱）治疗淋巴瘤。一项II期研究的初步结果。

Chemioterapia. 1984 Apr;3(2):79-82.

Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience.

Cancer Treat Rep. 1982 Nov;66(11):1909-16.

[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].

Nouv Presse Med. 1981 May 30;10(24):1997-9.

引用本文的文献

Applications of Friedel-Crafts reactions in total synthesis of natural products.傅-克反应在天然产物全合成中的应用。

RSC Adv. 2018 Dec 3;8(70):40061-40163. doi: 10.1039/c8ra07325b. eCollection 2018 Nov 28.

A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells.一种天然生物碱椭圆体的新型结构衍生物 MDPSQ，可诱导白血病细胞坏死。

Invest New Drugs. 2011 Aug;29(4):523-33. doi: 10.1007/s10637-009-9379-5. Epub 2010 Jan 13.

Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.腺苷和鸟苷中核糖与抗肿瘤药物N2-甲基-9-羟基玫瑰树碱醋酸酯的区域选择性芳基化反应

Proc Natl Acad Sci U S A. 1984 Mar;81(5):1297-301. doi: 10.1073/pnas.81.5.1297.

Bronchopulmonary effects of elliptinium in anesthetized dogs.椭圆玫瑰树碱对麻醉犬的支气管肺效应。

Cancer Chemother Pharmacol. 1984;13(3):240-1. doi: 10.1007/BF00269039.

Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium.

Invest New Drugs. 1984;2(3):263-5. doi: 10.1007/BF00175374.

Cardiac and vascular effects of elliptinium in guinea pigs. Involvement of a histaminergic mechanism.椭圆玫瑰树碱对豚鼠心脏和血管的影响。组胺能机制的参与。

Agents Actions. 1985 Jul;16(5):302-5. doi: 10.1007/BF01982862.

Sequence-selective binding of an ellipticine derivative to DNA.椭圆玫瑰树碱衍生物与DNA的序列选择性结合。

Nucleic Acids Res. 1990 Nov 11;18(21):6283-91. doi: 10.1093/nar/18.21.6283.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验